Tag: Cancer: Pancreatic
No-Drain Policy Noninferior for Major Morbidity in Distal Pancreatectomy
Grade B or C postoperative pancreatic fistula occurred in significantly fewer patients in the no-drain versus drain groups
FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer
Approval allows Onivyde (plus oxaliplatin, fluorouracil, and leucovorin) as first-line therapy
Opioid-Free Discharge Feasible After Pancreatectomy
In a recent study, there was an increase in the percentage of patients discharged opioid-free
Lorazepam Has Negative Impact on Survival in Pancreatic Cancer
Alprazolam reduced IL-6 in human pancreatic cancer-associated fibroblasts and was associated with improved progression-free survival
Rate of Positive Laparoscopy High for Patients With Pancreatic Cancer
Positive laparoscopy is associated with younger age, indeterminate extrapancreatic lesions on preoperative imaging, body/tail tumor location
Too Many Pancreatic Cancer Patients Not Offered Surgery
Percent of resections declined in Texas between 2004 and 2018
Learning Curve Length Estimated for Minimally Invasive Distal Pancreatectomy
Learning curve for primary textbook outcome was 85 procedures, with primary textbook outcome rate plateauing at 70 percent
ASCO: Minimally Invasive Noninferior to Open Surgery for Pancreatic Cancer
Radical resection occurred in 73 percent undergoing minimally invasive surgery, 69 percent undergoing open distal pancreatectomy
Artificial Intelligence Improves Prediction of Pancreatic Cancer
AI methods identified those at highest risk for pancreatic cancer within 36 months
Overweight, Obesity in Early, Middle Adulthood Increases Risk for GI Cancers
Risk not reduced with aspirin use three or more times per week for colorectal and noncolorectal cancers
